Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
24 participants
INTERVENTIONAL
2011-06-30
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Evaluate Periapical Healing Post Full Pulpotomy in Teeth With and Without Apical Periodontitis
NCT07179835
Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis
NCT05726357
PRP Regenerative Endodontics vs. Root Canal Treatment for Post-Op Pain and Healing in Mature Teeth
NCT07124962
Vital Pulp Therapy to Treat Irreversible Pulpitis
NCT00748280
Partial Pulpotomy in Mature Permanent Teeth With Signs and Symptoms of Irreversible Pulpits
NCT04870398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mineral Trioxide Aggregate
partial pulpotomy using White ProRoot MTA. Partial pulpotomy includes removal of 1mm of coronal pulp and covering the remaining tissue with a suitable material.
MTA
partial pulpotomy using White ProRoot MTA. Partial pulpotomy includes removal of 1mm of coronal pulp and covering the remaining tissue with a suitable material.
iRoot BP
Partial pulpotomy using iRoot BP. Partial pulpotomy includes removal of 1mm of coronal pulp and covering the remaining tissue with a suitable material. Bioaggregate is the first nano particle, water based root end filling material. This product includes calcium silicate, calcium hydroxide, hydroxy apatite and Tantalum oxide. Compared to MTA,this material lacks Bismuth oxide and calcium aluminate. iRoot BP is the injectable for of Bioaggregate (Injectable Root Bioaggregate Paste).
iRoot BP
Partial pulpotomy using iRoot BP. Partial pulpotomy includes removal of 1mm of coronal pulp and covering the remaining tissue with a suitable material. Bioaggregate is the first nano particle, water based root end filling material. This product includes calcium silicate, calcium hydroxide, hydroxy apatite and Tantalum oxide. Compared to MTA,this material lacks Bismuth oxide and calcium aluminate. iRoot BP is the injectable for of Bioaggregate (Injectable Root Bioaggregate Paste).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MTA
partial pulpotomy using White ProRoot MTA. Partial pulpotomy includes removal of 1mm of coronal pulp and covering the remaining tissue with a suitable material.
iRoot BP
Partial pulpotomy using iRoot BP. Partial pulpotomy includes removal of 1mm of coronal pulp and covering the remaining tissue with a suitable material. Bioaggregate is the first nano particle, water based root end filling material. This product includes calcium silicate, calcium hydroxide, hydroxy apatite and Tantalum oxide. Compared to MTA,this material lacks Bismuth oxide and calcium aluminate. iRoot BP is the injectable for of Bioaggregate (Injectable Root Bioaggregate Paste).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Their parents need to read and sign a fully informed form.
* They shouldn't have any systematic complication or take any medicine during the period of study.
* The teeth need to be free of any symptom, caries and decalcification
* They should give a normal response to pulp sensitivity tests (cold test) compared to the control tooth on the same quadrant.
* The teeth need to be free of mobility or swelling in the surrounding soft tissues and any sensitivity on palpation or percussion.
* On radiographic examination no apical lucency or PDL widening should be detected.
Exclusion Criteria
* tooth filling
* any caries
* hypocalcification
* The teeth showing apical lucency
* PDL widening on radiography
* sensitivity to cold, heat or bite
* The responses beyond the normal limits to pulp vitality testing
* Any medicine consumption
10 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Islamic Azad University, Sanandaj
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahta Fazlyab
post graduate student of Endodontic department, Dental Branch
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahta Fazlyab
Role: PRINCIPAL_INVESTIGATOR
Azad University, Dental Branch, Tehran
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azad University, Dental Branch, Tehran, Endodontic department
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRCT201102145804N2
Identifier Type: OTHER
Identifier Source: secondary_id
p/439/d
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.